Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Promising cancer treatments were found, but the manufacturer closed.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Pantethine may boost the immune system's ability to fight sarcoma.

Bortezomib chemotherapy can cause temporary skin rashes.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

COVID-19 affects patients on chemotherapy for gynecological cancer negatively.

The treatment was effective and tolerable for advanced gastric cancer.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Metformin may help treat neuroendocrine tumors.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Porocarcinoma generally has low rates of recurrence, spread to lymph nodes, and death.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

The new drug carriers show promise for better targeting and treating ovarian cancer.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.